With 7.44 million shares changed hands, the volume of the stock remained heavier than its average volume of 5.47 million shares. The 52-week range on ZOM shows that it touched its highest point at $0.20 and its lowest point at $0.10 during that stretch. It currently has a 1-year price target of $0.25. Beta for the stock currently stands at 1.16.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ZOM was down-trending over the past week, with a drop of -13.27%, but this was down by -14.33% over a month. Three-month performance dropped to -19.23% while six-month performance fell -20.34%. The stock lost -14.61% in the past year, while it has lost -12.83% so far this year. A look at the trailing 12-month EPS for ZOM yields -0.06 with Next year EPS estimates of -0.03. For the next quarter, that number is -0.01. This implies an EPS growth rate of -37.14% for this year and 37.50% for next year. EPS is expected to grow by 8.29% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 27.70%.
Float and Shares Shorts:
At present, 979.95 million ZOM shares are outstanding with a float of 962.66 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ZOM since 2 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.048 being high and -$0.048 being low. For ZOM, this leads to a yearly average estimate of -$0.048. Based on analyst estimates, the high estimate for the next quarter is -$0.01 and the low estimate is -$0.01. The average estimate for the next quarter is thus -$0.01.